Zymeworks (ZYME) Deferred Taxes (2021 - 2026)
Zymeworks' (ZYME) quarterly Deferred Taxes came in at $2.2 million in Q1 2026, up 436.59% year-on-year from $410000.0 in Q1 2025, and up 256.03% quarter-over-quarter from -$1.4 million in Q4 2025.
Zymeworks (ZYME) Deferred Taxes (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Deferred Taxes across 6 years of filings, most recently posting $2.2 million for Q1 2026.
- Deferred Taxes for Q1 2026 came in at $2.2 million, up 436.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $845000.0 (up 364.89% YoY), and the FY2025 annual result was -$945000.0, down 36.76% from the prior year.
- Deferred Taxes came in at $2.2 million for Q1 2026 at Zymeworks, up from -$1.4 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $2.2 million in Q1 2026 to a low of -$1.9 million in Q4 2022.
- The 5-year median for Deferred Taxes is $38000.0 (2024), against an average of -$36411.8.
- Across the five-year window, Deferred Taxes tumbled 249.76% in 2022 and soared 978.95% in 2025, its largest moves.
- Zymeworks' Deferred Taxes stood at -$1.9 million in 2022, then soared by 151.41% to $967000.0 in 2023, then tumbled by 216.55% to -$1.1 million in 2024, then declined by 25.11% to -$1.4 million in 2025, then surged by 256.03% to $2.2 million in 2026.
- The last three Deferred Taxes figures came in at $2.2 million (Q1 2026), -$1.4 million (Q4 2025), and $170000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | -1.41 Mn |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | -115,000.00 |
| Mar 31, 2025 | 410,000.00 |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | 204,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 967,000.00 |
| Sep 30, 2023 | -95,000.00 |
| Jun 30, 2023 | -106,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Dec 31, 2022 | -1.88 Mn |
| Sep 30, 2022 | 411,000.00 |
| Jun 30, 2022 | 265,000.00 |
| Mar 31, 2022 | -735,000.00 |
| Dec 31, 2021 | 1.26 Mn |